<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font25 { font-size : 25; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font25">and </span>
   <span class="font14">with </span>
   <span class="font14">for </span>
   <span class="font14">[]. </span>
   <span class="font14">COVID- </span>
   <span class="font13">The </span>
   <span class="font12">patients </span>
   <span class="font12">treatment </span>
   <span class="font12">are </span>
   <span class="font12">that </span>
   <span class="font11">viral </span>
   <span class="font11">virus </span>
   <span class="font11">SARS-CoV- </span>
   <span class="font11">coronavirus </span>
   <span class="font11">clinical </span>
   <span class="font11">has </span>
   <span class="font11">which </span>
   <span class="font11">efficacy </span>
   <span class="font11">from </span>
   <span class="font11">NCT </span>
   <span class="font11">also </span>
   <span class="font11">have </span>
   <span class="font11">drug </span>
   <span class="font11">been </span>
   <span class="font11">cell </span>
   <span class="font11">safety </span>
   <span class="font11">study </span>
   <span class="font11">activity </span>
   <span class="font11">antiviral </span>
   <span class="font10">its </span>
   <span class="font10">RNA </span>
   <span class="font10">combination </span>
   <span class="font10">host </span>
   <span class="font10">protein </span>
   <span class="font10">treat </span>
   <span class="font10">other </span>
   <span class="font10">against </span>
   <span class="font10">were </span>
   <span class="font10">respiratory </span>
   <span class="font10">novel </span>
   <span class="font10">trial </span>
   <span class="font10">SARS </span>
   <span class="font10">pneumonia </span>
   <span class="font10">Oral </span>
   <span class="font10">drugs </span>
   <span class="font10">route </span>
   <span class="font10">{background </span>
   <span class="font10">infection </span>
   <span class="font10">trials </span>
   <span class="font10">replication </span>
   <span class="font10">severe </span>
   <span class="font10">was </span>
   <span class="font10">(n.d.). </span>
   <span class="font10">evaluate </span>
   <span class="font10">this </span>
   <span class="font10">&amp;amp; </span>
   <span class="font10">(accessed </span>
   <span class="font10">SARS-CoV </span>
   <span class="font10">University </span>
   <span class="font10">spike </span>
   <span class="font10">treating </span>
   <span class="font10">China </span>
   <span class="font10">disease </span>
   <span class="font10">therapy </span>
   <span class="font10">cells </span>
   <span class="font10">COVID-. </span>
   <span class="font10">margin </span>
   <span class="font10">not </span>
   <span class="font10">therapeutic </span>
   <span class="font10">use </span>
   <span class="font10">hydroxychloroquine </span>
   <span class="font10">inhibits </span>
   <span class="font10">{border-style </span>
   <span class="font10">into </span>
   <span class="font10">like </span>
   <span class="font10">protease </span>
   <span class="font10">results </span>
   <span class="font10">showed </span>
   <span class="font10">... </span>
   <span class="font10">ACE- </span>
   <span class="font10">Medical </span>
   <span class="font10">RBV </span>
   <span class="font10">United </span>
   <span class="font10">complex </span>
   <span class="font10">plasma </span>
   <span class="font10">px;} </span>
   <span class="font10">#ffffff;} </span>
   <span class="font10">ARB </span>
   <span class="font10">COVID-, </span>
   <span class="font10">MERS-CoV </span>
   <span class="font10">cases </span>
   <span class="font10">https://clinicaltrials.gov/ct/show/NCT </span>
   <span class="font10">human </span>
   <span class="font10">membrane </span>
   <span class="font10">potential </span>
   <span class="font10">proteins </span>
   <span class="font10">repurposing </span>
   <span class="font10">April </span>
   <span class="font10">Clinical </span>
   <span class="font10">ClinicalTrials.gov, </span>
   <span class="font10">NCT, </span>
   <span class="font10">Research </span>
   <span class="font10">full </span>
   <span class="font10">immune </span>
   <span class="font10">receptor </span>
   <span class="font10">receptors </span>
   <span class="font10">syndrome </span>
   <span class="font10">text </span>
   <span class="font10">view </span>
   <span class="font10">RDV </span>
   <span class="font10">approved </span>
   <span class="font10">can </span>
   <span class="font10">than </span>
   <span class="font10">vaccines </span>
   <span class="font10">[], </span>
   <span class="font10">binding </span>
   <span class="font10">genome </span>
   <span class="font10">initiated </span>
   <span class="font10">lung </span>
   <span class="font10">polymerase </span>
   <span class="font10">randomized, </span>
   <span class="font10">research </span>
   <span class="font10">shown </span>
   <span class="font10">such </span>
   <span class="font10">their </span>
   <span class="font10">there </span>
   <span class="font10">effect </span>
   <span class="font10">effective </span>
   <span class="font10">effects </span>
   <span class="font10">entry </span>
   <span class="font10">fusion </span>
   <span class="font10">influenza </span>
   <span class="font10">inhibitors </span>
   <span class="font10">more </span>
   <span class="font10">new </span>
   <span class="font10">reported </span>
   <span class="font10">used </span>
   <span class="font10">virus, </span>
   <span class="font10">viruses </span>
   <span class="font10">vitro </span>
   <span class="font10">ChiCTR, </span>
   <span class="font10">Drug </span>
   <span class="font10">Hydroxychloroquine </span>
   <span class="font10">I.V </span>
   <span class="font10">MERS </span>
   <span class="font10">May </span>
   <span class="font10">This </span>
   <span class="font10">action </span>
   <span class="font10">being </span>
   <span class="font10">caused </span>
   <span class="font10">chloroquine </span>
   <span class="font10">current </span>
   <span class="font10">cytokine </span>
   <span class="font10">most </span>
   <span class="font10">oral </span>
   <span class="font10">thus </span>
   <span class="font10">will </span>
   <span class="font10">Fig. </span>
   <span class="font10">Health </span>
   <span class="font10">However, </span>
   <span class="font10">INF </span>
   <span class="font10">States </span>
   <span class="font10">[,]. </span>
   <span class="font10">acute </span>
   <span class="font10">control </span>
   <span class="font10">data </span>
   <span class="font10">days </span>
   <span class="font10">development </span>
   <span class="font10">dose </span>
   <span class="font10">due </span>
   <span class="font10">form </span>
   <span class="font10">given </span>
   <span class="font10">hospitalized </span>
   <span class="font10">infected </span>
   <span class="font10">inhibiting </span>
   <span class="font10">levels </span>
   <span class="font10">main </span>
   <span class="font10">mechanism </span>
   <span class="font10">open </span>
   <span class="font10">pandemic </span>
   <span class="font10">present </span>
   <span class="font10">storm </span>
   <span class="font10">CoVs </span>
   <span class="font10">FPV </span>
   <span class="font10">Plus </span>
   <span class="font10">TCZ </span>
   <span class="font10">ability </span>
   <span class="font10">adverse </span>
   <span class="font10">analysis </span>
   <span class="font10">assess </span>
   <span class="font10">associated </span>
   <span class="font10">based </span>
   <span class="font10">between </span>
   <span class="font10">broad-spectrum </span>
   <span class="font10">but </span>
   <span class="font10">concentration </span>
   <span class="font10">could </span>
   <span class="font10">domain </span>
   <span class="font10">first </span>
   <span class="font10">further </span>
   <span class="font10">interferon </span>
   <span class="font10">load </span>
   <span class="font10">mainly </span>
   <span class="font10">prevent </span>
   <span class="font10">production </span>
   <span class="font10">structure </span>
   <span class="font10">thereby </span>
   <span class="font10">through </span>
   <span class="font10">transmission </span>
   <span class="font10">while </span>
   <span class="font10">â€"Â </span>
   <span class="font10">-nCoV </span>
   <span class="font10">FDA </span>
   <span class="font10">Hospital, </span>
   <span class="font10">Oseltamivir </span>
   <span class="font10">With </span>
   <span class="font10">Wuhan, </span>
   <span class="font10">after </span>
   <span class="font10">cytokines </span>
   <span class="font10">demonstrated </span>
   <span class="font10">inhibition </span>
   <span class="font10">may </span>
   <span class="font10">recent </span>
   <span class="font10">reduce </span>
   <span class="font10">studies </span>
   <span class="font10">two </span>
   <span class="font10">various </span>
   <span class="font10">when </span>
   <span class="font10">â€" </span>
   <span class="font10">(COVID-) </span>
   <span class="font10">Infect. </span>
   <span class="font10">National </span>
   <span class="font10">Several </span>
   <span class="font10">Teicoplanin </span>
   <span class="font10">WHO </span>
   <span class="font10">acts </span>
   <span class="font10">aim </span>
   <span class="font10">amino </span>
   <span class="font10">any </span>
   <span class="font10">available </span>
   <span class="font10">azithromycin </span>
   <span class="font10">bacterial </span>
   <span class="font10">baricitinib </span>
   <span class="font10">binds </span>
   <span class="font10">controlled </span>
   <span class="font10">convalescent </span>
   <span class="font10">function </span>
   <span class="font10">group </span>
   <span class="font10">had </span>
   <span class="font10">half-life </span>
   <span class="font10">identified </span>
   <span class="font10">inhibit </span>
   <span class="font10">injection </span>
   <span class="font10">low </span>
   <span class="font10">many </span>
   <span class="font10">metabolized </span>
   <span class="font10">metal </span>
   <span class="font10">one </span>
   <span class="font10">phase </span>
   <span class="font10">possible </span>
   <span class="font10">process </span>
   <span class="font10">promising </span>
   <span class="font10">px; </span>
   <span class="font10">randomized </span>
   <span class="font10">reducing </span>
   <span class="font10">replication. </span>
   <span class="font10">role </span>
   <span class="font10">same </span>
   <span class="font10">several </span>
   <span class="font10">structural </span>
   <span class="font10">targets </span>
   <span class="font10">virus. </span>
   <span class="font10">{font-family </span>
   <span class="font10">â€² </span>
   <span class="font10">COVID-: </span>
   <span class="font10">Fellowship </span>
   <span class="font10">HCQ </span>
   <span class="font10">HIV </span>
   <span class="font10">Hospital </span>
   <span class="font10">Med. </span>
   <span class="font10">New </span>
   <span class="font10">Rev. </span>
   <span class="font10">SARS-CoV-, </span>
   <span class="font10">SARS-CoV. </span>
   <span class="font10">There </span>
   <span class="font10">acid </span>
   <span class="font10">agents </span>
   <span class="font10">along </span>
   <span class="font10">anti-viral </span>
   <span class="font10">block </span>
   <span class="font10">cellular </span>
   <span class="font10">clinicaltrials.govhttps://clinicaltrials.gov/ct/show/NCT </span>
   <span class="font10">cyclosporine </span>
   <span class="font10">effectiveness </span>
   <span class="font10">endocytosis </span>
   <span class="font10">enzyme </span>
   <span class="font10">font-size </span>
   <span class="font10">found </span>
   <span class="font10">genomic </span>
   <span class="font10">hepatitis </span>
   <span class="font10">including </span>
   <span class="font10">increase </span>
   <span class="font10">infections </span>
   <span class="font10">inflammatory </span>
   <span class="font10">involved </span>
   <span class="font10">kinase </span>
   <span class="font10">known </span>
   <span class="font10">leads </span>
   <span class="font10">life </span>
   <span class="font10">liver </span>
   <span class="font10">might </span>
   <span class="font10">mild </span>
   <span class="font10">moderate </span>
   <span class="font10">number </span>
   <span class="font10">open-label </span>
   <span class="font10">out </span>
   <span class="font10">pathway </span>
   <span class="font10">pathways </span>
   <span class="font10">pharmacokinetic </span>
   <span class="font10">potent </span>
   <span class="font10">preventing </span>
   <span class="font10">repurposed </span>
   <span class="font10">ribavirin </span>
   <span class="font10">ritonavir </span>
   <span class="font10">sirolimus </span>
   <span class="font10">site </span>
   <span class="font10">surface </span>
   <span class="font10">test </span>
   <span class="font10">these </span>
   <span class="font10">time </span>
   <span class="font10">towards </span>
   <span class="font10">transcription </span>
   <span class="font10">using </span>
   <span class="font10">who </span>
   <span class="font10">(for </span>
   <span class="font10">Azithromycin </span>
   <span class="font10">Cell </span>
   <span class="font10">Center, </span>
   <span class="font10">China, </span>
   <span class="font10">Chinese </span>
   <span class="font10">Coronavirus </span>
   <span class="font10">East </span>
   <span class="font10">Ebola </span>
   <span class="font10">Favipiravir </span>
   <span class="font10">IL- </span>
   <span class="font10">Institute, </span>
   <span class="font10">LPV </span>
   <span class="font10">Phase </span>
   <span class="font10">RTV </span>
   <span class="font10">Remdesivir </span>
   <span class="font10">These </span>
   <span class="font10">about </span>
   <span class="font10">administration </span>
   <span class="font10">agent </span>
   <span class="font10">antibodies </span>
   <span class="font10">because </span>
   <span class="font10">bioavailability </span>
   <span class="font10">blocks </span>
   <span class="font10">both </span>
   <span class="font10">case </span>
   <span class="font10">cleavage </span>
   <span class="font10">considered </span>
   <span class="font10">corticosteroids </span>
   <span class="font10">countries </span>
   <span class="font10">currently </span>
   <span class="font10">decrease </span>
   <span class="font10">dependent </span>
   <span class="font10">different </span>
   <span class="font10">double; </span>
   <span class="font10">early </span>
   <span class="font10">effectively </span>
   <span class="font10">efficiently </span>
   <span class="font10">enzymes </span>
   <span class="font10">epithelial </span>
   <span class="font10">family </span>
   <span class="font10">genetic </span>
   <span class="font10">immunoglobulin </span>
   <span class="font10">inhibitory </span>
   <span class="font10">interaction </span>
   <span class="font10">ions </span>
   <span class="font10">ivermectin </span>
   <span class="font10">leading </span>
   <span class="font10">major </span>
   <span class="font10">mediated </span>
   <span class="font10">multiple </span>
   <span class="font10">outbreak </span>
   <span class="font10">part </span>
   <span class="font10">properties </span>
   <span class="font10">proteases </span>
   <span class="font10">rapid </span>
   <span class="font10">release </span>
   <span class="font10">required </span>
   <span class="font10">similar </span>
   <span class="font10">strategies </span>
   <span class="font10">suspected </span>
   <span class="font10">synthesis </span>
   <span class="font10">teicoplanin </span>
   <span class="font10">they </span>
   <span class="font10">tissue </span>
   <span class="font10">vaccine </span>
   <span class="font10">within </span>
   <span class="font10">without </span>
   <span class="font10">world </span>
   <span class="font10">Acad. </span>
   <span class="font10">Agents </span>
   <span class="font10">Another </span>
   <span class="font10">Antimicrob. </span>
   <span class="font10">Baricitinib </span>
   <span class="font10">COVD- </span>
   <span class="font10">Care </span>
   <span class="font10">Chloroquine </span>
   <span class="font10">CoV </span>
   <span class="font10">Dr. </span>
   <span class="font10">Elsevier </span>
   <span class="font10">India </span>
   <span class="font10">Manipal </span>
   <span class="font10">Respiratory </span>
   <span class="font10">Rev </span>
   <span class="font10">Spike </span>
   <span class="font10">States, </span>
   <span class="font10">Study </span>
   <span class="font10">Table </span>
   <span class="font10">Treatment </span>
   <span class="font10">University, </span>
   <span class="font10">Versus </span>
   <span class="font10">[[], </span>
   <span class="font10">[]]. </span>
   <span class="font10">adenosine </span>
   <span class="font10">antibiotic </span>
   <span class="font10">arbidol </span>
   <span class="font10">authors </span>
   <span class="font10">bat </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">bound </span>
   <span class="font10">cause </span>
   <span class="font10">compounds </span>
   <span class="font10">conditions </span>
   <span class="font10">conducted </span>
   <span class="font10">cycle </span>
   <span class="font10">day </span>
   <span class="font10">decreasing </span>
   <span class="font10">develop </span>
   <span class="font10">developed </span>
   <span class="font10">developing </span>
   <span class="font10">dimer </span>
   <span class="font10">double </span>
   <span class="font10">elevated </span>
   <span class="font10">emerging </span>
   <span class="font10">forms </span>
   <span class="font10">highly </span>
   <span class="font10">hospitalization </span>
   <span class="font10">humans </span>
   <span class="font10">important </span>
   <span class="font10">include </span>
   <span class="font10">increased </span>
   <span class="font10">induced </span>
   <span class="font10">inflammation </span>
   <span class="font10">infusion </span>
   <span class="font10">inhibited </span>
   <span class="font10">inhibitor </span>
   <span class="font10">inhibitor, </span>
   <span class="font10">initiated. </span>
   <span class="font10">internalization </span>
   <span class="font10">intracellular </span>
   <span class="font10">investigational </span>
   <span class="font10">less </span>
   <span class="font10">lipid </span>
   <span class="font10">maximum </span>
   <span class="font10">molecular </span>
   <span class="font10">mortality </span>
   <span class="font10">obtained </span>
   <span class="font10">ongoing </span>
   <span class="font10">outcomes </span>
   <span class="font10">positive </span>
   <span class="font10">preclinical </span>
   <span class="font10">prevents </span>
   <span class="font10">profile </span>
   <span class="font10">progress </span>
   <span class="font10">proteins, </span>
   <span class="font10">recently </span>
   <span class="font10">related </span>
   <span class="font10">resulting </span>
   <span class="font10">review </span>
   <span class="font10">side </span>
   <span class="font10">since </span>
   <span class="font10">small </span>
   <span class="font10">solid; </span>
   <span class="font10">specific </span>
   <span class="font10">started </span>
   <span class="font10">strategy </span>
   <span class="font10">suppressing </span>
   <span class="font10">system </span>
   <span class="font10">target </span>
   <span class="font10">targeting </span>
   <span class="font10">therapeutics </span>
   <span class="font10">tocilizumab </span>
   <span class="font10">tract </span>
   <span class="font10">under </span>
   <span class="font10">upon </span>
   <span class="font10">vaccines, </span>
   <span class="font10">vital </span>
   <span class="font10">yet </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(Fig. </span>
   <span class="font10">(NCT) </span>
   <span class="font10">Acute </span>
   <span class="font10">Both </span>
   <span class="font10">Cancer </span>
   <span class="font10">Centre </span>
   <span class="font10">Cyclosporine </span>
   <span class="font10">DNA </span>
   <span class="font10">DRV </span>
   <span class="font10">Delhi </span>
   <span class="font10">France </span>
   <span class="font10">GS- </span>
   <span class="font10">Government </span>
   <span class="font10">India, </span>
   <span class="font10">Institute </span>
   <span class="font10">Interferon </span>
   <span class="font10">International </span>
   <span class="font10">Ivermectin </span>
   <span class="font10">Middle </span>
   <span class="font10">Natl. </span>
   <span class="font10">Patients </span>
   <span class="font10">Pegylated </span>
   <span class="font10">Ribavirin </span>
   <span class="font10">S.C </span>
   <span class="font10">SARS-CoV, </span>
   <span class="font10">SARS-CoV-. </span>
   <span class="font10">Sci. </span>
   <span class="font10">Sciences, </span>
   <span class="font10">Severe </span>
   <span class="font10">Spain </span>
   <span class="font10">Syndrome </span>
   <span class="font10">They </span>
   <span class="font10">Virus </span>
   <span class="font10">Wuhan </span>
   <span class="font10">absorbed </span>
   <span class="font10">accessory </span>
   <span class="font10">administered </span>
   <span class="font10">adults </span>
   <span class="font10">affected </span>
   <span class="font10">affinity </span>
   <span class="font10">alone </span>
   <span class="font10">already </span>
   <span class="font10">among </span>
   <span class="font10">animal </span>
   <span class="font10">antibiotics </span>
   <span class="font10">belong </span>
   <span class="font10">better </span>
   <span class="font10">blocking </span>
   <span class="font10">bold </span>
   <span class="font10">candidates </span>
   <span class="font10">care </span>
   <span class="font10">carried </span>
   <span class="font10">centre </span>
   <span class="font10">changes </span>
   <span class="font10">chronic </span>
   <span class="font10">class </span>
   <span class="font10">clinically </span>
   <span class="font10">combating </span>
   <span class="font10">components </span>
   <span class="font10">condition </span>
   <span class="font10">corona </span>
   <span class="font10">corticosteroid </span>
   <span class="font10">courier; </span>
   <span class="font10">death </span>
   <span class="font10">design </span>
   <span class="font10">distribution </span>
   <span class="font10">dromedary </span>
   <span class="font10">em; </span>
   <span class="font10">enter </span>
   <span class="font10">epidemic </span>
   <span class="font10">expected </span>
   <span class="font10">failure </span>
   <span class="font10">followed </span>
   <span class="font10">following </span>
   <span class="font10">formation </span>
   <span class="font10">four </span>
   <span class="font10">future </span>
   <span class="font10">having </span>
   <span class="font10">helicase </span>
   <span class="font10">high </span>
   <span class="font10">higher </span>
   <span class="font10">however, </span>
   <span class="font10">identifying </span>
   <span class="font10">immunosuppressive </span>
   <span class="font10">includes </span>
   <span class="font10">infection, </span>
   <span class="font10">infection. </span>
   <span class="font10">infection: </span>
   <span class="font10">infections, </span>
   <span class="font10">infectious </span>
   <span class="font10">infectivity </span>
   <span class="font10">information </span>
   <span class="font10">interferon-Î± </span>
   <span class="font10">intravenous </span>
   <span class="font10">investigate </span>
   <span class="font10">it's </span>
   <span class="font10">key </span>
   <span class="font10">lungs </span>
   <span class="font10">making </span>
   <span class="font10">management </span>
   <span class="font10">market </span>
   <span class="font10">mechanisms </span>
   <span class="font10">monoclonal </span>
   <span class="font10">must </span>
   <span class="font10">namely </span>
   <span class="font10">non-structural </span>
   <span class="font10">nsp </span>
   <span class="font10">nuclear </span>
   <span class="font10">open-label, </span>
   <span class="font10">origin </span>
   <span class="font10">palm </span>
   <span class="font10">particular </span>
   <span class="font10">patients, </span>
   <span class="font10">patients. </span>
   <span class="font10">performed </span>
   <span class="font10">pharmacodynamic </span>
   <span class="font10">pharmacokinetics </span>
   <span class="font10">placebo </span>
   <span class="font10">play </span>
   <span class="font10">pneumonia, </span>
   <span class="font10">proliferation </span>
   <span class="font10">protein. </span>
   <span class="font10">proteins. </span>
   <span class="font10">pt;} </span>
   <span class="font10">reaction </span>
   <span class="font10">released </span>
   <span class="font10">resource </span>
   <span class="font10">respect </span>
   <span class="font10">response </span>
   <span class="font10">responses </span>
   <span class="font10">rheumatoid </span>
   <span class="font10">route, </span>
   <span class="font10">seafood </span>
   <span class="font10">secretion </span>
   <span class="font10">shows </span>
   <span class="font10">some </span>
   <span class="font10">study, </span>
   <span class="font10">successfully </span>
   <span class="font10">symptomatic </span>
   <span class="font10">symptoms </span>
   <span class="font10">tablets </span>
   <span class="font10">taken </span>
   <span class="font10">tested </span>
   <span class="font10">those </span>
   <span class="font10">times </span>
   <span class="font10">total </span>
   <span class="font10">triphosphate </span>
   <span class="font10">uses </span>
   <span class="font10">via </span>
   <span class="font10">virological </span>
   <span class="font10">volume </span>
   <span class="font10">well </span>
   <span class="font10">where </span>
   <span class="font10">widely </span>
   <span class="font10">would </span>
   <span class="font10">zinc </span>
  </p>
 </body>
</html>
